Your browser doesn't support javascript.
loading
Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss.
Hamel, Charlotte C; Snijders, Marcus P L M; Coppus, Sjors F P J; Vandenbussche, Frank P H A; Braat, Didi D M; Adang, Eddy M M.
Affiliation
  • Hamel CC; Radboud University Medical Centre, Department of Obstetrics and Gynaecology, Nijmegen, GA, The Netherlands.
  • Snijders MPLM; Department of Obstetrics and Gynaecology, Canisius-Wilhelmina Hospital, Nijmegen, GS, The Netherlands.
  • Coppus SFPJ; Department of Obstetrics and Gynaecology, Canisius-Wilhelmina Hospital, Nijmegen, GS, The Netherlands.
  • Vandenbussche FPHA; Maxima Medical Centre, Department of Obstetrics and Gynaecology, Veldhoven, DB, The Netherlands.
  • Braat DDM; Radboud University Medical Centre, Department of Obstetrics and Gynaecology, Nijmegen, GA, The Netherlands.
  • Adang EMM; Department of Obstetrics and Gynaecology, Helios Klinikum Duisburg, Duisburg, Germany.
PLoS One ; 17(2): e0262894, 2022.
Article in En | MEDLINE | ID: mdl-35139105
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mifepristone Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mifepristone Type of study: Clinical_trials / Health_economic_evaluation Aspects: Patient_preference Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2022 Document type: Article Affiliation country: Países Bajos Country of publication: Estados Unidos